Cases & Deals

  • Home
  • Practices
  • Guided Therapeutics issues $3 million of Senior Convertible Notes in private placement

Share

Guided Therapeutics issues $3 million of Senior Convertible Notes in private placement

April 2014

Client(s) Guided Therapeutics, Inc.

Jones Day advised Guided Therapeutics, Inc., a medical device company developing a biophotonic cancer detection testing platform, in connection with its issuance of $3 million in aggregate principal amount of 6% Senior Convertible Notes in a private placement to an institutional investor.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.